Algocell is an AI-powered bioprocess modeling platform designed to help cell-based companies optimize their production. We combine traditional bioprocess engineering with machine learning to create Digital Twins. This allows you to simulate thousands of scenarios in-silico, drastically reducing trial-and-error experiments, optimizing cell productivity, and accelerating your time-to-market.

Our platform uses Hybrid Models - combining biological mechanistic models with advanced AI. You simply upload a small amount of new or historical biological and engineering data. The system calibrates this data to create a highly accurate Digital Twin of your bioprocess, allowing you to validate conceptual designs and predict outcomes without running endless physical experiments.

The Algocell platform is capable of modeling and optimizing virtually all process dynamics, conditions, and strategies. This includes optimizing inoculum size, complex feeding strategies, gas regimes, the exact time of induction, and temperature shifts. Furthermore, the model can optimize the ratio between biomass and productivity, multi-carbon source feeding rates, and analyze how the addition or removal of specific substances (like growth factors) affects overall cellular metabolism.

Algocell is built specifically for cell-based companies. Our platform is highly effective for optimizing precision fermentation, cultivated food production, and complex cell culture bioprocesses. Whether you are in foodtech, biotech, or pharmaceuticals, our models adapt to your specific cell line metabolism and equipment constraints.

One of our core advantages is that you don't need massive datasets to get started. Customers can begin by simply uploading their existing historical data to receive initial predictions. If the initial model is not accurate enough, the Algocell platform will automatically export specific protocols for 4 to 8 targeted experimental runs. The data from these experiments will calibrate the model and find the full design space of your bioprocess.

Yes! Scaling up is one of the biggest bottlenecks in biomanufacturing. Algocell utilizes precise engineering models tailored to your specific equipment to meticulously plan the scale-up process. This ensures a seamless and predictable transition from R&D pilot phases directly to your CMO or in-house manufacturing facility, minimizing failure risks.

At an industrial manufacturing scale, even marginal improvements in yield translate to massive financial gains. Algocell’s digital twins continuously analyze and optimize large-scale bioprocesses by fine-tuning feeding strategies, mass transfer rates, and metabolic parameters. By maximizing production titers, minimizing batch variations, and preventing costly run failures, our platform significantly increases your overall commercial revenue and profit margins without requiring additional hardware infrastructure.

Absolutely. Beyond R&D and scale-up, Algocell provides in-production optimization. Our platform offers real-time insights and model-based control systems that predict production bottlenecks, allowing you to adjust parameters on the fly, maximize titer production, and maintain consistent batch-to-batch quality.

By shifting from physical trial-and-error to in-silico simulations, our partners typically reduce the number of required experiments by up to 70-80%. This drastically cuts experimental expenses, lowers overall production costs, and significantly accelerates your speed to market.

ata security is our top priority. We employ enterprise-grade encryption and strict privacy protocols to ensure that all of your historical data, cell line information, and proprietary bioprocess protocols remain entirely confidential and secure at all times.

Our platform is designed for seamless integration. The Digital Twin models are customized to account for the specific engineering aspects, physics, and constraints of your existing bioreactors and production infrastructure, ensuring the optimized protocols we generate are immediately actionable in your facility.

The onboarding process is fast and highly collaborative. Once you provide your initial baseline data, our system works quickly to calibrate the Hybrid Models. Most teams are able to generate their first bioprocess Digital Twin and start running simulations and optimization processes within 2 weeks.